234 related articles for article (PubMed ID: 20184741)
41. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
42. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
43. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
[TBL] [Abstract][Full Text] [Related]
44. TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.
Bahari G; Hashemi M; Naderi M; Taheri M
Asian Pac J Cancer Prev; 2016; 17(8):3959-62. PubMed ID: 27644645
[TBL] [Abstract][Full Text] [Related]
45. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
[TBL] [Abstract][Full Text] [Related]
46. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
[TBL] [Abstract][Full Text] [Related]
47. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
[TBL] [Abstract][Full Text] [Related]
48. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
[TBL] [Abstract][Full Text] [Related]
49. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Cervantes F; Sanchez J; Garate L; Barrios M; Castillejo JA; Navarro G; Colomer D; Prosper F; Heiniger A; Torres A
Oncogene; 2005 Nov; 24(48):7213-23. PubMed ID: 16170379
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.
Haider Z; Landfors M; Golovleva I; Erlanson M; Schmiegelow K; Flægstad T; Kanerva J; Norén-Nyström U; Hultdin M; Degerman S
Blood Cancer J; 2020 Apr; 10(4):45. PubMed ID: 32345961
[TBL] [Abstract][Full Text] [Related]
51. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.
Sato H; Oka T; Shinnou Y; Kondo T; Washio K; Takano M; Takata K; Morito T; Huang X; Tamura M; Kitamura Y; Ohara N; Ouchida M; Ohshima K; Shimizu K; Tanimoto M; Takahashi K; Matsuoka M; Utsunomiya A; Yoshino T
Am J Pathol; 2010 Jan; 176(1):402-15. PubMed ID: 20019193
[TBL] [Abstract][Full Text] [Related]
52. Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.
Heller G; Topakian T; Altenberger C; Cerny-Reiterer S; Herndlhofer S; Ziegler B; Datlinger P; Byrgazov K; Bock C; Mannhalter C; Hörmann G; Sperr WR; Lion T; Zielinski CC; Valent P; Zöchbauer-Müller S
Leukemia; 2016 Sep; 30(9):1861-8. PubMed ID: 27211271
[TBL] [Abstract][Full Text] [Related]
53. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
[TBL] [Abstract][Full Text] [Related]
54. Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
Stumpel DJ; Schneider P; van Roon EH; Boer JM; de Lorenzo P; Valsecchi MG; de Menezes RX; Pieters R; Stam RW
Blood; 2009 Dec; 114(27):5490-8. PubMed ID: 19855078
[TBL] [Abstract][Full Text] [Related]
55. The DNA methylome of pediatric acute lymphoblastic leukemia.
Davidsson J; Lilljebjörn H; Andersson A; Veerla S; Heldrup J; Behrendtz M; Fioretos T; Johansson B
Hum Mol Genet; 2009 Nov; 18(21):4054-65. PubMed ID: 19679565
[TBL] [Abstract][Full Text] [Related]
56. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
57. GPX3 promoter is methylated in chronic myeloid leukemia.
Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521
[TBL] [Abstract][Full Text] [Related]
58. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S
Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687
[TBL] [Abstract][Full Text] [Related]
59. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
60. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
